Featured Research

from universities, journals, and other organizations

Bed rest can harm, instead of help, in pregnancy complications, research suggests

Date:
October 29, 2010
Source:
SAGE Publications
Summary:
Bed rest may not be the best option for preventing preterm labor and may even cause harm to the mother and baby, according to an integrative literature review.

Bed rest may not be the best option for preventing preterm labor and may even cause harm to the mother and baby, according to an integrative literature review in a special issue on "Women's Health Across the Lifespan" in Biological Research for Nursing.

Bed rest or activity restriction, prescribed for up to 1 million women in the U.S. annually to treat pregnancy complications, is based on the assumptions that it is

(a) effective in preventing preterm birth and

(b) safe for both the mother and fetus.

According to the study, however, research over more than two decades has failed to support these assumptions.

Author Judith A. Maloni, PhD, RN, FAAN, Professor in the Bolton School of Nursing, Case Western Reserve University has been conducting research on pregnancy bed rest for more than two decades. In this article, Dr. Maloni reviewed all known research about bed rest, high-risk pregnancy, preterm labor, and how those relate to the side-effects of bone loss, thrombosis, depression, stress, and other symptoms.

In addition to the impact of an overall negative pregnancy experience for the mother, which has largely been ignored by medical professionals, the researcher found a number of troubling issues with bed rest, including such concerns as:

  • Loss of muscle function, muscle atrophy, sore muscles
  • Bone loss
  • Maternal weight loss, lower fetal weight
  • Fatigue, sleep cycle changes, boredom
  • Both antepartum and postpartum depression, mood changes
  • Nasal congestion, reflux, indigestion, back and muscle aches

"Nurses can challenge bed-rest treatment by functioning as advocates for women and educating them about the evidence for bed-rest treatment as well as the risks and benefits," writes the author. "If research does eventually uncover convincing evidence of the efficacy of bed rest, investigators and care providers must pay strict attention to the prevention and treatment of adverse maternal and infant side effects. Success in the effort to reduce preterm birth may only come about when we, as researchers and providers, reconceptualize prenatal care as only one part of a lifelong effort to optimize women's health, beginning at birth."


Story Source:

The above story is based on materials provided by SAGE Publications. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. A. Maloni. Antepartum Bed Rest for Pregnancy Complications: Efficacy and Safety for Preventing Preterm Birth. Biological Research For Nursing, 2010; 12 (2): 106 DOI: 10.1177/1099800410375978

Cite This Page:

SAGE Publications. "Bed rest can harm, instead of help, in pregnancy complications, research suggests." ScienceDaily. ScienceDaily, 29 October 2010. <www.sciencedaily.com/releases/2010/10/101029121744.htm>.
SAGE Publications. (2010, October 29). Bed rest can harm, instead of help, in pregnancy complications, research suggests. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/10/101029121744.htm
SAGE Publications. "Bed rest can harm, instead of help, in pregnancy complications, research suggests." ScienceDaily. www.sciencedaily.com/releases/2010/10/101029121744.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins